MSActiveSource

Disease-modifying treatments

About 80% of people with multiple sclerosis (MS) are suffering from relapsing-remitting multiple sclerosis (RRMS) at onset. People with RRMS experience attacks or relapses (when symptoms occur suddenly) followed by periods of good or complete remission (when symptoms disappear or improve for a period of time). Over time their condition will progress, with about 50% of people developing secondary progressive multiple sclerosis (SPMS) during the first 10 years of their illness. For more information, visit Types of MS

Disease modifying treatments (DMTs) aim to slow the progression of the condition for patients with RRMS by reducing the number and severity of relapses. DMTs are also used in some people who have progressed to SPMS but are still experiencing relapses.

Click on each of the drug names below to find out more about how they work and when they are used.